Journal
JOURNAL OF IMMUNOLOGY
Volume 182, Issue 5, Pages 3008-3015Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0800680
Keywords
-
Categories
Funding
- National Institutes of Health [A1035237]
- National Institute of Allergy and Infectious Diseases [A1069161]
- Fonds de Recherche en Sante Qudbec
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035237, R01AI069161, R21AI035237] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The interferon regulatory factor (IRF) family member IRF-8 participates in IFN-gamma-dependent transcriptional activation of genes containing in their promoter regions IFN-stimulated response element or IFN-gamma activation site elements. To test the role of IRF-8 in host defenses against tuberculosis, BXH-2 mice, which bear a defective IRF-8(R294c) allele, were challenged with low doses of virulent Mycobacterium tuberculosis via the i.v. and aerosol routes. BXH-2 mice were found to be extremely susceptible to M. tuberculosis, as demonstrated by rapid and uncontrolled microbial replication in spleen, liver, and lungs leading to very early death. The BXH-2 defect was expressed very early (10 days postinfection) as uncontrolled intracellular pathogen replication in NOS2-expressing lung macrophages, impaired granuloma formation, rapid dissemination of the infection to distant sites, and rapid necrosis of infected tissues. There was complete absence of IL-12p40 induction, severely reduced IFN-gamma production, and impaired T cell priming in the lungs of infected BXH-2, highlighting the critical role of IRF-8 in this process. Collectively, these results identify IRF-8 as a critical regulator of host defenses against tuberculosis. The Journal of Immunology, 2009, 182: 3008-3015.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available